798 related articles for article (PubMed ID: 33082015)
21. COVID-19 Vaccine: A comprehensive status report.
Kaur SP; Gupta V
Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
[TBL] [Abstract][Full Text] [Related]
22. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
Samrat SK; Tharappel AM; Li Z; Li H
Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196
[TBL] [Abstract][Full Text] [Related]
23. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
24. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.
Kalita P; Padhi AK; Zhang KYJ; Tripathi T
Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359
[TBL] [Abstract][Full Text] [Related]
25. The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
Su QD; Yi Y; Zou YN; Jia ZY; Qiu F; Wang F; Yin WJ; Zhou WT; Zhang S; Yu PC; Bi SL; Shen LP; Wu GZ
Vaccine; 2020 Jul; 38(32):5071-5075. PubMed ID: 32513514
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of SARS-CoV-2 vaccine candidates.
Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F
Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445
[TBL] [Abstract][Full Text] [Related]
27. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
28. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
Marchan J
Hum Immunol; 2020; 81(10-11):588-595. PubMed ID: 32888767
[TBL] [Abstract][Full Text] [Related]
29. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
30. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
[TBL] [Abstract][Full Text] [Related]
31. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
Front Immunol; 2020; 11():2008. PubMed ID: 33013857
[TBL] [Abstract][Full Text] [Related]
32. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
[TBL] [Abstract][Full Text] [Related]
33. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
Banerjee A; Santra D; Maiti S
J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788
[TBL] [Abstract][Full Text] [Related]
34. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
35. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
Abdulla F; Adhikari UK; Uddin MK
Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
[TBL] [Abstract][Full Text] [Related]
36. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
[TBL] [Abstract][Full Text] [Related]
37. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.
Panda PK; Arul MN; Patel P; Verma SK; Luo W; Rubahn HG; Mishra YK; Suar M; Ahuja R
Sci Adv; 2020 Jul; 6(28):eabb8097. PubMed ID: 32691011
[TBL] [Abstract][Full Text] [Related]
38. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
Crooke SN; Ovsyannikova IG; Kennedy RB; Poland GA
Sci Rep; 2020 Aug; 10(1):14179. PubMed ID: 32843695
[TBL] [Abstract][Full Text] [Related]
39. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
40. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]